Article Versions Notes

Akter T, Bulbul MRH, Sama-ae I, Azadi MA, Nira KN, Al-Araby SQ, Deen JI, Rafi MKJ, Saha S, Ezaj MMA, et al. Sour Tamarind Is More Antihypertensive than the Sweeter One, as Evidenced by In Vivo Biochemical Indexes, Ligand–Protein Interactions, Multitarget Interactions, and Molecular Dynamic Simulation. Nutrients. 2023; 15(15):3402. https://doi.org/10.3390/nu15153402

Akter, Taslima, Md. Rakibul Hassan Bulbul, Imran Sama-ae, M. A. Azadi, Kamrun Nahar Nira, Salahuddin Quader Al-Araby, Jobaier Ibne Deen, Md. Khalid Juhani Rafi, Srabonti Saha, Md. Muzahid Ahmed Ezaj, and et al. 2023. "Sour Tamarind Is More Antihypertensive than the Sweeter One, as Evidenced by In Vivo Biochemical Indexes, Ligand–Protein Interactions, Multitarget Interactions, and Molecular Dynamic Simulation" Nutrients 15, no. 15: 3402. https://doi.org/10.3390/nu15153402

Akter, T., Bulbul, M. R. H., Sama-ae, I., Azadi, M. A., Nira, K. N., Al-Araby, S. Q., Deen, J. I., Rafi, M. K. J., Saha, S., Ezaj, M. M. A., & Rahman, M. A. (2023). Sour Tamarind Is More Antihypertensive than the Sweeter One, as Evidenced by In Vivo Biochemical Indexes, Ligand–Protein Interactions, Multitarget Interactions, and Molecular Dynamic Simulation. Nutrients, 15(15), 3402. https://doi.org/10.3390/nu15153402